CANADIAN PUBLIC HEALTH ASSOCIATION ASSOCIATION CANADIENNE DE SANTE PUBLIQUE 1565 Carling Avenue, Suite 400, Ottawa, Ontario, Canada K1Z 8R1[removed]FAX[removed]E- mail C. Électronique: [removed] Inter - David Butler - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-09-13 13:42:08 David Butler-Jones Public Health Agency of Canada Health policy Health economics Chief Public Health Officer of Canada Medical Officer for Health Public health Health Canada Chief Medical Officer Health Health in Canada Year of birth missing		CANADIAN PUBLIC HEALTH ASSOCIATION ASSOCIATION CANADIENNE DE SANTE PUBLIQUE 1565 Carling Avenue, Suite 400, Ottawa, Ontario, Canada K1Z 8R1[removed]FAX[removed]E- mail/C. Électronique: [removed] Inter Add to Reading List Source URL: www.cpha.ca Download Document from Source Website File Size: 29,60 KB Share Document on Facebook

	2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES DocID: 1vr6Q - View Document
	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	Postdoctoral Position in Computational Toxicology Co-hosted by CCAAM/CaCVAM, Health Canada, and Environment and Climate Change Canada We are seeking a highly motivated and experienced Postdoctoral Research Fellow to DocID: 1vlea - View Document
	Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w DocID: 1vkfE - View Document
	PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes    DocID: 1vjI2 - View Document